Correlation Between Nautilus Biotechnology and Nurix Therapeutics

Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nautilus Biotechnology and Nurix Therapeutics, you can compare the effects of market volatilities on Nautilus Biotechnology and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and Nurix Therapeutics.

Diversification Opportunities for Nautilus Biotechnology and Nurix Therapeutics

-0.13

Correlation Coefficient

Nautilus Biotechnology  Nurix Therapeutics

Good diversification

The 3 months correlation between Nautilus and Nurix is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Nautilus Biotechnology and Nurix Therapeutics

Given the investment horizon of 90 days Nautilus Biotechnology is expected to generate 1.54 times more return on investment than Nurix Therapeutics. However, Nautilus Biotechnology is 1.54 times more volatile than Nurix Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  67.00  in Nautilus Biotechnology on May 6, 2025 and sell it today you would earn a total of  8.10  from holding Nautilus Biotechnology or generate 12.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Nautilus Biotechnology  vs.  Nurix Therapeutics

Nautilus Biotechnology

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nautilus Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Nautilus Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Nurix Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nurix Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Nurix Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nautilus Biotechnology and Nurix Therapeutics

The main advantage of trading using opposite Nautilus Biotechnology and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.

The idea behind Nautilus Biotechnology and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.